Cargando…

Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications

SIMPLE SUMMARY: This work describes a nanoplatform for deep-tissue photodynamic therapy (PDT) and imaging using upconverting nanoparticles functionalized with eosin Y (EY), a photosensitizer (PS) that have been demonstrated to be effective even in hypoxic environments. These structures take advantag...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Peña, Gabriel, Simón-Fuente, Silvia, Ortgies, Dirk H., Moliné, María Ángeles, Martín Rodríguez, Emma, Sanz-Rodríguez, Francisco, Ribagorda, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817929/
https://www.ncbi.nlm.nih.gov/pubmed/36612098
http://dx.doi.org/10.3390/cancers15010102
_version_ 1784864860928999424
author López-Peña, Gabriel
Simón-Fuente, Silvia
Ortgies, Dirk H.
Moliné, María Ángeles
Martín Rodríguez, Emma
Sanz-Rodríguez, Francisco
Ribagorda, María
author_facet López-Peña, Gabriel
Simón-Fuente, Silvia
Ortgies, Dirk H.
Moliné, María Ángeles
Martín Rodríguez, Emma
Sanz-Rodríguez, Francisco
Ribagorda, María
author_sort López-Peña, Gabriel
collection PubMed
description SIMPLE SUMMARY: This work describes a nanoplatform for deep-tissue photodynamic therapy (PDT) and imaging using upconverting nanoparticles functionalized with eosin Y (EY), a photosensitizer (PS) that have been demonstrated to be effective even in hypoxic environments. These structures take advantage of the capability of the nanoparticles to be excited by 800 nm near infrared light, where penetration is higher in comparison with visible light commonly used in PDT, and the thermal load is minimum. Additionally, the combination with UCNPs enables the transport of EY into the cell, which is not possible for EY alone. The generation of reactive oxygen species (ROS) under 800 nm light inside the cell becomes therefore possible based on upconversion and energy transfer processes. These UCNPs also present long lasting infrared fluorescence under 808 nm excitation, thus enabling their use as deep tissue bioimaging agent during PDT. ABSTRACT: Functionalized upconverting nanoparticles (UCNPs) are promising theragnostic nanomaterials for simultaneous therapeutic and diagnostic purposes. We present two types of non-toxic eosin Y (EY) nanoconjugates derived from UCNPs as novel nanophotosensitizers (nano-PS) and deep-tissue bioimaging agents employing light at 800 nm. This excitation wavelength ensures minimum cell damage, since the absorption of water is negligible, and increases tissue penetration, enhancing the specificity of the photodynamic treatment (PDT). These UCNPs are uniquely qualified to fulfil three important roles: as nanocarriers, as energy-transfer materials, and as contrast agents. First, the UCNPs enable the transport of EY across the cell membrane of living HeLa cells that would not be possible otherwise. This cellular internalization facilitates the use of such EY-functionalized UCNPs as nano-PS and allows the generation of reactive oxygen species (ROS) under 800 nm light inside the cell. This becomes possible due to the upconversion and energy transfer processes within the UCNPs, circumventing the excitation of EY by green light, which is incompatible with deep tissue applications. Moreover, the functionalized UCNPs present deep tissue NIR-II fluorescence under 808 nm excitation, thus demonstrating their potential as bioimaging agents in the NIR-II biological window.
format Online
Article
Text
id pubmed-9817929
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98179292023-01-07 Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications López-Peña, Gabriel Simón-Fuente, Silvia Ortgies, Dirk H. Moliné, María Ángeles Martín Rodríguez, Emma Sanz-Rodríguez, Francisco Ribagorda, María Cancers (Basel) Article SIMPLE SUMMARY: This work describes a nanoplatform for deep-tissue photodynamic therapy (PDT) and imaging using upconverting nanoparticles functionalized with eosin Y (EY), a photosensitizer (PS) that have been demonstrated to be effective even in hypoxic environments. These structures take advantage of the capability of the nanoparticles to be excited by 800 nm near infrared light, where penetration is higher in comparison with visible light commonly used in PDT, and the thermal load is minimum. Additionally, the combination with UCNPs enables the transport of EY into the cell, which is not possible for EY alone. The generation of reactive oxygen species (ROS) under 800 nm light inside the cell becomes therefore possible based on upconversion and energy transfer processes. These UCNPs also present long lasting infrared fluorescence under 808 nm excitation, thus enabling their use as deep tissue bioimaging agent during PDT. ABSTRACT: Functionalized upconverting nanoparticles (UCNPs) are promising theragnostic nanomaterials for simultaneous therapeutic and diagnostic purposes. We present two types of non-toxic eosin Y (EY) nanoconjugates derived from UCNPs as novel nanophotosensitizers (nano-PS) and deep-tissue bioimaging agents employing light at 800 nm. This excitation wavelength ensures minimum cell damage, since the absorption of water is negligible, and increases tissue penetration, enhancing the specificity of the photodynamic treatment (PDT). These UCNPs are uniquely qualified to fulfil three important roles: as nanocarriers, as energy-transfer materials, and as contrast agents. First, the UCNPs enable the transport of EY across the cell membrane of living HeLa cells that would not be possible otherwise. This cellular internalization facilitates the use of such EY-functionalized UCNPs as nano-PS and allows the generation of reactive oxygen species (ROS) under 800 nm light inside the cell. This becomes possible due to the upconversion and energy transfer processes within the UCNPs, circumventing the excitation of EY by green light, which is incompatible with deep tissue applications. Moreover, the functionalized UCNPs present deep tissue NIR-II fluorescence under 808 nm excitation, thus demonstrating their potential as bioimaging agents in the NIR-II biological window. MDPI 2022-12-23 /pmc/articles/PMC9817929/ /pubmed/36612098 http://dx.doi.org/10.3390/cancers15010102 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
López-Peña, Gabriel
Simón-Fuente, Silvia
Ortgies, Dirk H.
Moliné, María Ángeles
Martín Rodríguez, Emma
Sanz-Rodríguez, Francisco
Ribagorda, María
Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title_full Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title_fullStr Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title_full_unstemmed Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title_short Eosin Y-Functionalized Upconverting Nanoparticles: Nanophotosensitizers and Deep Tissue Bioimaging Agents for Simultaneous Therapeutic and Diagnostic Applications
title_sort eosin y-functionalized upconverting nanoparticles: nanophotosensitizers and deep tissue bioimaging agents for simultaneous therapeutic and diagnostic applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817929/
https://www.ncbi.nlm.nih.gov/pubmed/36612098
http://dx.doi.org/10.3390/cancers15010102
work_keys_str_mv AT lopezpenagabriel eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT simonfuentesilvia eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT ortgiesdirkh eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT molinemariaangeles eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT martinrodriguezemma eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT sanzrodriguezfrancisco eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications
AT ribagordamaria eosinyfunctionalizedupconvertingnanoparticlesnanophotosensitizersanddeeptissuebioimagingagentsforsimultaneoustherapeuticanddiagnosticapplications